Please assess the completion status of the following clinical trial:

Trial Title: Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years~* The first episode of femoro-popliteal deep vein thrombosis (DVT)~* Verification of DVT by duplex ultrasound~* Informed consent signed~Exclusion Criteria:~* Suspicion of pulmonary embolism (PE)~* Verified PE~* Bilateral DVT~* Contraindications for rivaroxaban (in accordance with the official instructions)~* Contraindications for diosmin (in accordance with the official instructions)~* Active cancer~* Verified severe thrombophilia (antiphospholipid antibodies, deficiency of proteins C, S, antithrombin 3)~* Use of other anticoagulants for more than 7 days from the DVT verification~* Impossibility of using compression stocking after 3 days from DVT verification~* Performed surgical intervention on the superficial or deep veins of the lower extremities (thrombolysis, thrombectomy, vein ligation, implantation of the inferior cava filter)~* Continuous use of other drugs that affect the hemostasis system (except for acetylsalicylic acid in a dose of not more than 100 mg).~* Low compliance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental: Rivaroxaban + Diosmin + Stockings (Type: EXPERIMENTAL): treatment of deep vein thrombosis with anticoagulation (rivaroxaban), elastic compression stockings and additional prescription of diosmin
- Control: Rivaroxaban + Stockings only (Type: ACTIVE_COMPARATOR): standard treatment of deep vein thrombosis with anticoagulation (rivaroxaban) and elastic compression stockings

Based on this trial design, predict the completion outcome and termination type (if applicable).